Published in

Elsevier, The Lancet, 10269(397), p. 99-111, 2021

DOI: 10.1016/s0140-6736(20)32661-1

Links

Tools

Export citation

Search in Google Scholar

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Journal article published in 2020 by Ina Schim van der Loeff, Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, Lily Y. Weckx, Catherine M. Green, Pedro M. Folegatti ORCID, Parvinder K. Aley, Brian Angus, Vicky L. Baillie ORCID, Shaun L. Barnabas, Qasim E. Bhorat, Christopher A. Green, Sagida Bibi, Carmen Briner and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO